Position in CYTK
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$8,238,750
+$1,884,750 QoQ
Shares Held
125,000
+25.0% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Impax Asset Management Group plc holds $78,417,640 across 7 Biotechnology names. CYTK ranks #5 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
152,444 | $30,435,444 | |
| 2 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
350,000 | $12,712,000 | |
| 3 | TECH |
BIO-TECHNE Corp
|
195,000 | $10,190,700 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
300,000 | $8,310,000 | |
| 5 | CYTK |
Cytokinetics Inc
This page
|
125,000 | $8,238,750 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
225,000 | $6,684,750 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,134 | $1,845,996 |
All Filings in CYTK
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,238,750 | 125,000 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $6,354,000 | 100,000 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $9,618,000 | 175,000 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $5,782,000 | 175,000 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $7,033,250 | 175,000 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $8,232,000 | 175,000 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $6,600,000 | 125,000 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $6,772,500 | 125,000 | Shares | Defined | 2024-11-08 | |
| No filing history on record for this holder in this stock. | ||||||